Table 1.
Baseline Demographic Characteristics and Correlations With Left Ventricular (LV) Mass/Body Surface Area (BSA) (n=905)
| Mean (SD) or Proportion | LV Mass/BSA | |
|---|---|---|
| Characteristics | Correlation (95% CI)* | |
| Age, y | 50.5 (6.6) | 0.15 (0.08, 0.21)* |
| Body weight, kg | 80.6 (11.3) | 0.15 (0.09, 0.22)* |
| Body mass index, kg/m2 | 26.7 (3.1) | 0.14 (0.08, 0.21)* |
| BSA, m2 | 1.94 (0.15) | 0.14 (0.07, 0.20)* |
| Cigarette pack‐years of smoking* | 7.6 (15.7) | −0.04 (−0.10, 0.03) |
| Systolic blood pressure, mm Hg | 132.3 (15.4) | 0.14 (0.07, 0.20)* |
| Diastolic blood pressure, mm Hg | 88.7 (10.2) | 0.07 (0.01, 0.14)* |
| Serum total cholesterol, mmol/L | 5.78 (1.00) | −0.01 (−0.07, 0.06) |
| Serum LDL‐cholesterol, mmol/L | 3.87 (0.92) | −0.03 (−0.10, 0.03) |
| Serum HDL‐cholesterol, mmol/L | 1.27 (0.29) | 0.09 (0.02, 0.15)* |
| Cardiorespiratory fitness, mL/kg per minute* | 32.1 (7.8) | 0.04 (−0.03, 0.10) |
| Categorical variable | Change relative to ref category* | |
| Smoker, % | 31.2 | −2.22 (−5.78, 1.34) |
| Diabetes, %* | 4.9 | 2.56 (−5.34, 10.45) |
| Atrial fibrillation, % | 1.2 | 4.45 (−7.44, 16.33) |
| Hypertension, % | 25.8 | 2.77 (−0.55, 6.09) |
| Family history of coronary heart disease, % | 48.9 | −1.42 (−4.74, 1.89) |
| Regular use of medication | ||
| Antihypertensive drugs, % | 13.9 | 9.95 (5.56, 14.35)* |
| Statins,% | 6.2 | −5.94 (−26.39, 14.52) |
| β‐Blockers, % | 9.6 | 7.68 (2.75, 12.62)* |
| Aspirin, % | 9.5 | −1.29 (−6.68, 4.11) |
HDL indicates high‐density lipoprotein; LDL, low‐density lipoprotein.
P<0.05 for statistical significance.
Correlation coefficient (95% CI).
Pack‐years denotes the lifelong exposure to smoking which was estimated as the product of years smoked and the number of tobacco products smoked daily at the time of examination.
Cardiorespiratory fitness was defined as the highest value or the plateau of oxygen uptake during the exercise testing.
Reference is the category without the characteristic (eg, change relative to the reference).
Diabetes was defined as fasting blood glucose ≥6.1 mmol/L or a clinical diagnosis of diabetes with either dietary, oral, or insulin treatment.